Epperly Melissa B,

Affiliations

  • Director at Nautilus Biotechnology Inc. (NAUT), 2025-06-25
  • at Roivant Sciences Ltd. (ROIV), 2025-04-22
  • at Kinnate Biopharma Inc. (KNTE), 2024-04-05
  • Chief Financial Officer at Zentalis Pharmaceuticals Inc. (ZNTL), 2024-02-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZNTL $52.00 8,285 $430,800.12 266,685 2021-08-19 Filing
ZNTL $52.00 1,326 $68,948.02 258,400 2021-08-18 Filing
ZNTL $18.00 20,000 $360,000.00 297,529 2020-04-07 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZNTL $11.44 2,573 $29,435.12 451,449 2024-02-12 Filing
ZNTL $11.54 8,669 $100,040.26 454,022 2024-02-02 Filing
ZNTL $19.91 888 $17,680.26 387,691 2023-10-04 Filing
ZNTL $19.43 4,594 $89,245.34 388,579 2023-10-04 Filing
ZNTL $19.98 5,227 $104,410.89 392,048 2023-02-14 Filing